Publications by authors named "Paola Loria"

Claim this Profile
N
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study.
Erica Villa, Rosina Critelli, Barbara Lei, Guido Marzocchi, Calogero Cammà, Paola Loria

Gut· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease.
Amedeo Lonardo, Stefano Ballestri, Giovanni Targher, Paola Loria

Expert Rev Gastroenterol Hepatol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary lymphoma of the spleen mimicking simple benign cysts: contrast-enhanced ultrasonography and other imaging findings.
Stefano Ballestri, Amedeo Lonardo, Dante Romagnoli, Luisa Losi, Paola Loria

J Med Ultrason (2001)· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-alcoholic fatty liver disease: diagnosis and investigation.
Fabio Nascimbeni, Paola Loria, Vlad Ratziu

Dig Dis· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.
Amedeo Lonardo, Stefano Ballestri, Giulio Marchesini, Paul Angulo, Paola Loria

Dig Liver Dis· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population.
Marco Bertolotti, Chiara Mussi, Elisa Pellegrini, Alessandro Magni, Marina Del Puppo, Paola Loria

Clin Interv Aging· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonalcoholic fatty liver disease and aging: epidemiology to management.
Marco Bertolotti, Amedeo Lonardo, Chiara Mussi, Enrica Baldelli, Elisa Pellegrini, Paola Loria

World J Gastroenterol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen.
Amedeo Lonardo, Luigi Elio Adinolfi, Luciano Restivo, Stefano Ballestri, Dante Romagnoli, Paola Loria

World J Gastroenterol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms.
Luigi E Adinolfi, Rosa Zampino, Luciano Restivo, Amedeo Lonardo, Barbara Guerrera, Paola Loria

World J Gastroenterol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD.
Lucia Carulli, Mauro Maurantonio, Lionel Hebbard, Enrica Baldelli, Paola Loria

Curr Pharm Des· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo degradation of cholesterol to bile acids is reduced in patients receiving parenteral nutrition.
Lucia Carulli, Marina Del Puppo, Claudia Anzivino, Lisa Zambianchi, Chiara Gabbi, Paola Loria

JPEN J Parenter Enteral Nutr· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD.
Amedeo Lonardo, Silvia Sookoian, Michel Chonchol, Paola Loria, Giovanni Targher

Curr Pharm Des· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease.
Stefano Ballestri, Amedeo Lonardo, Stefano Bonapace, Christopher D Byrne, Paola Loria

World J Gastroenterol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From NAFLD in clinical practice to answers from guidelines.
Fabio Nascimbeni, Raluca Pais, Stefano Bellentani, Christopher Paul Day, Vlad Ratziu, Paola Loria

J Hepatol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD).
Federica Scaglioni, Mariano Marino, Stefania Ciccia, Alessia Procaccini, M Busacchi, Paola Loria

Clin Res Hepatol Gastroenterol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of serum fetuin-A levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography.
Stefano Ballestri, Erica Meschiari, Enrica Baldelli, Francesca E Musumeci, Dante Romagnoli, Paola Loria

Metab Syndr Relat Disord· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population.
Claudia Anzivino, Maria Rosaria Odoardi, Erica Meschiari, Enrica Baldelli, Fabio Facchinetti, Paola Loria

Dig Liver Dis· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities.
Giovanni Guaraldi, Giulia Besutti, Chiara Stentarelli, Stefano Zona, Luca Nocetti, Paola Loria

Antivir Ther· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver and diabetes. A vicious circle.
Paola Loria, Amedeo Lonardo, Frank Anania

Hepatol Res· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease.
Chiara Gabbi, Marco Bertolotti, Claudia Anzivino, Daria Macchioni, Marina Del Puppo, Paola Loria

Dig Liver Dis· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential for statins in the chemoprevention and management of hepatocellular carcinoma.
Amedeo Lonardo, Paola Loria

J Gastroenterol Hepatol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD.
Stefano Ballestri, Amedeo Lonardo, Dante Romagnoli, Lucia Carulli, Luisa Losi, Paola Loria

Liver Int· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis.
Amedeo Lonardo, Fabio Nascimbeni, Stefano Ballestri, Maria Teresa Mascia, Rossella Iori, Paola Loria

Hepatol Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
If steatosis is the atherosclerosis of the liver, are statins the "aspirin" for steatosis?
Amedeo Lonardo, Paola Loria

Dig Liver Dis· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis.
Luigi E Adinolfi, Luciano Restivo, Rosa Zampino, Barbara Guerrera, Amedeo Lonardo, Paola Loria

Atherosclerosis· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis